| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| | | IP | CI | | Oxis 6 Turbuhaler | 60 unidose(s) | 15.49 | 33.25 | 10 % | | Inhalation Powder: Formoteroli Fumaras Dihydricus 6 µg | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Oxis 12 Turbuhaler | 60 unidose(s) | 20.30 | 38.50 | 10 % | | Inhalation Powder: Formoteroli Fumaras Dihydricus 12 µg | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Foradil 12 mcg | 60 Capsule(s) | 23.28 | 41.75 | 10 % | | Trockenpulver-Kapseln zur Inhalation: Formoteroli Fumaras Dihydricus 12 µg | Sandoz Pharmaceuticals AG | B / SL | FB | G |
|
| | | IP | CI | | Onbrez Breezhaler 150 mcg | 30 Capsule(s) | 30.58 | 49.65 | 10 % | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Onbrez Breezhaler 300 mcg | 30 Capsule(s) | 35.86 | 55.40 | 10 % | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Onbrez Breezhaler 150 mcg | 90 Capsule(s) | 77.97 | 101.20 | 10 % | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Onbrez Breezhaler 300 mcg | 90 Capsule(s) | 91.47 | 115.90 | 10 % | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Onbrez Breezhaler 150 mcg | 90 Capsule(s) | | | k.A. | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B | FB | G |
| | | IP | CI | | Onbrez Breezhaler 300 mcg | 90 Capsule(s) | | | k.A. | | Pulver Hartkapseln zur Inhalation (mit Inhalator): 2 Active Agents | Novartis Pharma Schweiz AG | B | FB | G |
|
| | | IP | CI | | Vannair 100/6 | 120 unidose(s) | 42.16 | 62.25 | 10 % | | Metered dose aerosol: 2 Active Agents | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Vannair 200/6 | 120 unidose(s) | 47.90 | 68.50 | 10 % | | Metered dose aerosol: 2 Active Agents | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Symbicort 100/6 Turbuhaler | 60 unidose(s) | 22.40 | 40.80 | 10 % | | Inhalation Powder: 2 Active Agents | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Symbicort 100/6 Turbuhaler | 120 unidose(s) | 39.38 | 59.25 | 10 % | | Inhalation Powder: 2 Active Agents | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Symbicort 200/6 Turbuhaler | 60 unidose(s) | 25.44 | 44.10 | 10 % | | Inhalation Powder: 2 Active Agents | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Symbicort 200/6 Turbuhaler | 120 unidose(s) | 44.74 | 65.05 | 10 % | | Inhalation Powder: 2 Active Agents | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Symbicort 400/12 Turbuhaler | 60 unidose(s) | 40.84 | 60.85 | 10 % | | Inhalation Powder: 2 Active Agents | AstraZeneca AG | B / SL | FB | G |
| | | | | | Symbicort 200/6 Turbuhaler | 60 | | | k.A. | | Inhalation Powder: 2 Active Agents | EurimPharm Swiss AG | B | FB | G |
| | | | | | Symbicort 200/6 Turbuhaler | 120 | | | k.A. | | Inhalation Powder: 2 Active Agents | EurimPharm Swiss AG | B | FB | G |
|
| | | IP | CI | | Foster 100 μg / 6 μg | 120 | 48.00 | 68.60 | 10 % | | Solution pour inhalation en flacon pressurisé: 2 Active Agents | Chiesi SA | B / SL | FB | G |
| | | IP | CI | | Foster 200 μg / 6 μg | 120 | 49.01 | 69.70 | 10 % | | solution pour inhalation en flacon pressurisé: 2 Active Agents | Chiesi SA | B / SL | FB | G |
| | | IP | CI | | Foster 100 μg / 6 μg | 240 | | | k.A. | | Solution pour inhalation en flacon pressurisé: 2 Active Agents | Chiesi SA | B | FB | G |
|
| | | IP | CI | | Flutiform 50/5 | 120 | 30.89 | 50.00 | 10 % | | Druckgasinhalation: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | G |
| | | IP | CI | | Flutiform 125/5 | 120 | 41.27 | 61.30 | 10 % | | Druckgasinhalation: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | G |
| | | IP | CI | | Flutiform 250/10 | 120 | 58.69 | 80.25 | 10 % | | Druckgasinhalation: 2 Active Agents | Mundipharma Medical Company, Hamilton, Bermuda, Basel Branch | B / SL | FB | G |
|
| | | IP | CI | | Atectura Breezhaler 150/80 μg | 30 | 32.28 | 51.50 | 10 % | | Inhalation Powder: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Atectura Breezhaler 150/80 μg | 90 | 96.74 | 121.65 | 10 % | | Inhalation Powder: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Atectura Breezhaler 150/160 μg | 30 | 32.28 | 51.50 | 10 % | | Inhalation Powder: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Atectura Breezhaler 150/160 μg | 90 | 96.74 | 121.65 | 10 % | | Inhalation Powder: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Atectura Breezhaler 150/320 μg | 30 | 32.28 | 51.50 | 10 % | | Inhalation Powder: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | | Atectura Breezhaler 150/320 μg | 90 | 96.74 | 121.65 | 10 % | | Inhalation Powder: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
|
| | | IP | CI | | Berodual N | 200 inhalation(s) | 12.21 | 29.70 | k.A. | | Metered dose aerosol: 2 Active Agents | Boehringer Ingelheim (Schweiz) GmbH | B | FB | G |
|
| | | IP | CI | PP | Ultibro Breezhaler 110/50 | 30 Capsule(s) | 45.57 | 66.00 | 10 % | | Inhalation Powder: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | PP | Ultibro Breezhaler 110/50 | 90 | 136.55 | 164.90 | 10 % | | Inhalation Powder: 2 Active Agents | Novartis Pharma Schweiz AG | B / SL | FB | G |
|
| L | | IP | CI | | Trimbow 172/5/9 mcg | | 58.03 | 79.55 | 10 % | | | Chiesi SA | B / SL | FB | G |
| L | | IP | CI | | Trimbow 172/5/9 mcg | 360 | 173.55 | 205.15 | 10 % | | | Chiesi SA | B / SL | FB | G |
| L | | IP | CI | | Trimbow 88/5/9 | 120 | 54.22 | 75.40 | 10 % | | poudre pour inhalation: 3 Active Agents | Chiesi SA | B / SL | FB | G |
| L | | IP | CI | | Trimbow 88/5/9 | 360 | 162.11 | 192.70 | 10 % | | poudre pour inhalation: 3 Active Agents | Chiesi SA | B / SL | FB | G |
| L | | IP | CI | | Trimbow 87/5/9 mcg | 120 | 54.22 | 75.40 | 10 % | | solution pour inhalation en flacon pressurisé: 3 Active Agents | Chiesi SA | B / SL | FB | G |
| L | | IP | CI | | Trimbow 87/5/9 mcg | 360 | 162.11 | 192.70 | 10 % | | solution pour inhalation en flacon pressurisé: 3 Active Agents | Chiesi SA | B / SL | FB | G |
| | | IP | CI | | Trimbow 172/5/9 mcg | | | | k.A. | | | Chiesi SA | B | FB | G |
| | | IP | CI | | Trimbow 172/5/9 mcg | 240 | | | k.A. | | | Chiesi SA | B | FB | G |
| | | IP | CI | | Trimbow 87/5/9 mcg | 60 | | | k.A. | | solution pour inhalation en flacon pressurisé: 3 Active Agents | Chiesi SA | B | FB | G |
|
| L | | IP | CI | | Trixeo Aerosphere 5/7.2/160 μg | 120 | 53.10 | 74.15 | 10 % | | | AstraZeneca AG | B / SL | FB | G |
| L | | IP | CI | | Trixeo Aerosphere 5/7.2/160 μg | 360 | 159.31 | 189.70 | 10 % | | | AstraZeneca AG | B / SL | FB | G |
|
| L | | IP | CI | | Enerzair Breezhaler 150/50/160 μg | 30 | 54.58 | 75.80 | 10 % | | | Novartis Pharma Schweiz AG | B / SL | FB | G |
| L | | IP | CI | | Enerzair Breezhaler 150/50/160 μg | 90 | 163.74 | 194.50 | 10 % | | | Novartis Pharma Schweiz AG | B / SL | FB | G |
|
| | | IP | CI | | Qvar Autohaler 100 µg | 200 inhalation(s) | 20.00 | 38.15 | 10 % | | Metered dose aerosol: Beclometasoni Dipropionas 100 µg | Teva Pharma AG | B / SL | FB | G |
| | | IP | CI | | Beclo Orion Easyhaler | 200 | 26.11 | 44.80 | 10 % | | Inhalation Powder: Beclometasoni Dipropionas 200 µg | Orion Pharma AG | B / SL | FB | G |
| | | IP | CI | | Qvar Autohaler 50 µg | 100 inhalation(s) | | | k.A. | | Metered dose aerosol: Beclometasoni Dipropionas 50 µg | Teva Pharma AG | B | FB | G |
| | | IP | CI | | Qvar Autohaler 50 µg | 200 inhalation(s) | | | k.A. | | Metered dose aerosol: Beclometasoni Dipropionas 50 µg | Teva Pharma AG | B | FB | G |
| | | IP | CI | | Qvar Autohaler 100 µg | 100 inhalation(s) | | | k.A. | | Metered dose aerosol: Beclometasoni Dipropionas 100 µg | Teva Pharma AG | B | FB | G |
|
| | | IP | CI | | Pulmicort Respules 0,25 mg/mL | 20 1 ampoule(s) à 2 ml | 20.22 | 38.40 | 10 % | | Suspension: Budesonidum | AstraZeneca AG | B / SL / SO | FB | G |
| | | IP | CI | | Pulmicort Respules 0,5 mg/mL | 20 1 ampoule(s) à 2 ml | 37.34 | 57.05 | 10 % | | Suspension: Budesonidum | AstraZeneca AG | B / SL / SO | FB | G |
| | | IP | CI | | Pulmicort Turbuhaler 100 | 200 unidose(s) | 16.05 | 33.85 | 10 % | | Inhalation Powder: Budesonidum 100 µg | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Pulmicort Turbuhaler 200 | 200 unidose(s) | 32.08 | 51.30 | 10 % | | Inhalation Powder: Budesonidum 200 µg | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Pulmicort Turbuhaler 400 | 50 unidose(s) | 16.05 | 33.85 | 10 % | | Inhalation Powder: Budesonidum 400 µg | AstraZeneca AG | B / SL | FB | G |
| | | IP | CI | | Pulmicort Respules 0,125 mg/mL | 20 1 ampoule(s) à 2 ml | 15.97 | 33.80 | 10 % | | Suspension: Budesonidum | AstraZeneca AG | B / SL | FB | G |
|
| | | IP | CI | | Axotide 50 | inhalation(s) à 0.05 mg | 7.73 | 17.65 | 10 % | | Metered dose aerosol: Fluticasoni Propionas 50 µg | GlaxoSmithKline AG | B / SL | FB | G |
| | | IP | CI | | Axotide 125 | inhalation(s) à 0.125 mg | 16.87 | 34.75 | 10 % | | Metered dose aerosol: Fluticasoni Propionas 125 µg | GlaxoSmithKline AG | B / SL | FB | G |
| | | IP | CI | | Axotide 250 | inhalation(s) à 0.25 mg | 26.84 | 45.60 | 10 % | | Metered dose aerosol: Fluticasoni Propionas 250 µg | GlaxoSmithKline AG | B / SL | FB | G |
| | | IP | CI | | Axotide Diskus 100 | 60 inhalation(s) | 7.73 | 17.65 | 10 % | | Mutlidosen-Pulverinhalator: Fluticasoni Propionas 100 µg | GlaxoSmithKline AG | B / SL | FB | G |
| | | IP | CI | | Axotide Diskus 250 | 60 inhalation(s) | 16.87 | 34.75 | 10 % | | Mutlidosen-Pulverinhalator: Fluticasoni Propionas 250 µg | GlaxoSmithKline AG | B / SL | FB | G |
| | | IP | CI | | Axotide Diskus 500 | 60 inhalation(s) | 26.84 | 45.60 | 10 % | | Mutlidosen-Pulverinhalator: Fluticasoni Propionas 500 µg | GlaxoSmithKline AG | B / SL | FB | G |
| | | IP | CI | | Axotide Nebules 0,5 mg/2 mL | 10 unidose(s) | 9.06 | 18.60 | k.A. | | gebrauchsfertige Suspension zur Inhalation: Fluticasoni-17 Propionas | GlaxoSmithKline AG | B | FB | G |
| | | IP | CI | | Axotide Nebules 2 mg/2 mL | 10 unidose(s) | 32.80 | 54.05 | k.A. | | gebrauchsfertige Suspension zur Inhalation: Fluticasoni-17 Propionas 2 mg | GlaxoSmithKline AG | B | FB | G |
|
| | SIP | IP | CI | | Alvesco 80 ug | 120 inhalation(s) | 17.49 | 35.45 | 10 % | | Metered dose aerosol: Ciclesonidum 80 µg | Azurity Pharmaceuticals Switzerland GmbH | B / SL | FB | G |
| | SIP | IP | CI | | Alvesco 160 ug | 120 inhalation(s) | 21.90 | 40.25 | 10 % | | Metered dose aerosol: Ciclesonidum 160 µg | Azurity Pharmaceuticals Switzerland GmbH | B / SL | FB | G |
|
| | | IP | CI | | Arnuity Ellipta 90 mcg | 30 unidose(s) | 14.71 | 32.40 | 10 % | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | G |
| | | IP | CI | | Arnuity Ellipta 90 mcg | 3 x 30 | 44.13 | 64.40 | 10 % | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 90 µg | GlaxoSmithKline AG | B / SL | FB | G |
| | | IP | CI | | Arnuity Ellipta 182 mcg | 30 unidose(s) | 24.12 | 42.65 | 10 % | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg | GlaxoSmithKline AG | B / SL | FB | G |
| | | IP | CI | | Arnuity Ellipta 182 mcg | 3 x 30 | 72.36 | 95.10 | 10 % | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 182 µg | GlaxoSmithKline AG | B / SL | FB | G |
| | | IP | CI | | Arnuity Ellipta 46 mcg | 30 | | | k.A. | | Einzeldosiertes Pulver zur Inhalation: Fluticasoni Furoas 46 µg | GlaxoSmithKline AG | B | FB | G |
|
| | | IP | CI | | Atrovent 250 mcg/2 ml | 60 unidose(s) | 14.36 | 32.05 | k.A. | | Lösung für einen Vernebler (gebrauchsfertige Einzeldosen): Ipratropii Bromidum Anhydricum 250µg / 2ml | Boehringer Ingelheim (Schweiz) GmbH | B | FB | G |
| | | | CI | | Atrovent | 15 ml | 13.12 | 29.80 | k.A. | | Metered dose aerosol: Ipratropii Bromidum 20 µg | Boehringer Ingelheim (Schweiz) GmbH | B | FB | G |
|
| | | IP | CI | PP | Seebri Breezhaler | 30 Capsule(s) | 27.92 | 46.80 | 10 % | | Mikrogramm: Glycopyrronium 50 µg | Novartis Pharma Schweiz AG | B / SL | FB | G |
| | | IP | CI | PP | Seebri Breezhaler | 90 Capsule(s) | 83.75 | 107.50 | 10 % | | Mikrogramm: Glycopyrronium 50 µg | Novartis Pharma Schweiz AG | B / SL | FB | G |
|
| | | IP | CI | | Gynipral | 5 1 ampoule(s) à 2 ml | | 26.65 | 10 % | | Infusion solution: Hexoprenalini Sulfas 5 µg/ml | Takeda Pharma AG | B | FB | G |
| | | IP | CI | | Gynipral | 5 1 ampoule(s) à 5 ml | | 42.95 | 10 % | | Infusion solution: Hexoprenalini Sulfas 5 µg/ml | Takeda Pharma AG | B | FB | G |
|
| | | IP | | | Aminophyllin Amino | 10 x 10 ml | | | k.A. | | | Amino AG, Fabrikation pharmazeutischer und chemischer Produkte | ● B | FB | G |
| | | IP | | | Escophyllin i.v. | 5 ampoule(s) à 10 ml | 3.35 | 8.05 | k.A. | | Injection solution: Theophyllinum 190 mg | G. Streuli & Co. AG | B / SO | FB | G |
| | | IP | | | Escophyllin i.v. | 10 ampoule(s) à 10 ml | | 13.35 | k.A. | | Injection solution: Theophyllinum 190 mg | G. Streuli & Co. AG | B | FB | G |
| | | IP | | | Escophyllin i.v. | 50 ampoule(s) à 10 ml | | 44.45 | k.A. | | Injection solution: Theophyllinum 190 mg | G. Streuli & Co. AG | B | FB | G |
| | | IP | CI | | Phyllotemp Continus 225 | 60 Tablet(s) | 12.74 | 27.30 | k.A. | | Delayed release tablets: Theophyllinum Et Ethylendiaminum 225 mg | Mundipharma Medical Company | B | FB | G |
|
| | | IP | CI | CM | Lukair 4 mg | 28 Tablet(s) | 18.46 | 36.40 | 10 % | | Chewing tablets: Montelukastum 4 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | CM | Lukair 4 mg | 98 Tablet(s) | 64.71 | 86.40 | 10 % | | Chewing tablets: Montelukastum 4 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | CM | Lukair 5 mg | 28 Tablet(s) | 18.39 | 36.30 | 10 % | | Chewing tablets: Montelukastum 5 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | CM | Lukair 5 mg | 98 Tablet(s) | 64.48 | 86.20 | 10 % | | Chewing tablets: Montelukastum 5 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | CM | Lukair 4 mg | 28 Sachet(s) | 19.87 | 37.85 | 20 % | | Granulate: Montelukastum 4 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | CM | Lukair 10 mg | 28 Tablet(s) | 18.39 | 36.35 | 10 % | | Coated tablets: Montelukastum 10 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | CM | Lukair 10 mg | 98 Tablet(s) | 64.48 | 86.20 | 10 % | | Coated tablets: Montelukastum 10 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Singulair | 28 Tablet(s) | 18.47 | 36.40 | 10 % | | Coated tablets: Montelukastum 10 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Singulair | 98 Tablet(s) | 64.48 | 86.20 | 10 % | | Coated tablets: Montelukastum 10 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Singulair 5 mg | 28 Tablet(s) | 18.47 | 36.40 | 10 % | | Kautabletten für Kinder: Montelukastum 5 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Singulair 5 mg | 98 Tablet(s) | 64.48 | 86.20 | 10 % | | Kautabletten für Kinder: Montelukastum 5 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Singulair 4 mg | 28 Tablet(s) | 18.46 | 36.40 | 10 % | | Kautabletten für Kleinkinder: Montelukastum 4 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Singulair 4 mg | 98 Tablet(s) | 64.44 | 86.15 | 10 % | | Kautabletten für Kleinkinder: Montelukastum 4 mg | Organon GmbH | B / SL / SO | FB | G |
| | | IP | CI | | Montelukast Sandoz 4 mg | 28 Tablet(s) | 16.79 | 34.70 | 10 % | | Chewing tablets: Montelukastum 4 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Sandoz 4 mg | 98 Tablet(s) | 58.62 | 80.15 | 10 % | | Chewing tablets: Montelukastum 4 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Sandoz 5 mg | 28 Tablet(s) | 16.79 | 34.70 | 10 % | | Chewing tablets: Montelukastum 5 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Sandoz 5 mg | 98 Tablet(s) | 58.62 | 80.15 | 10 % | | Chewing tablets: Montelukastum 5 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Spirig HC 4 | 28 Tablet(s) | 16.80 | 34.70 | 10 % | | Chewing tablets: Montelukastum 4 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Spirig HC 4 | 98 Tablet(s) | 58.62 | 80.15 | 10 % | | Chewing tablets: Montelukastum 4 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Spirig HC 5 | 28 Tablet(s) | 16.80 | 34.70 | 10 % | | Chewing tablets: Montelukastum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Spirig HC 5 | 98 Tablet(s) | 58.62 | 80.15 | 10 % | | Chewing tablets: Montelukastum 5 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast-Mepha 4 mg | 28 Tablet(s) | 16.79 | 34.70 | 10 % | | Chewing tablets: Montelukastum 4 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast-Mepha 4 mg | 98 Tablet(s) | 58.62 | 80.15 | 10 % | | Chewing tablets: Montelukastum 4 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast-Mepha 5 mg | 28 Tablet(s) | 16.79 | 34.70 | 10 % | | Chewing tablets: Montelukastum 5 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast-Mepha 5 mg | 98 Tablet(s) | 58.62 | 80.15 | 10 % | | Chewing tablets: Montelukastum 5 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Sandoz 4 | 28 Sachet(s) | 16.79 | 34.70 | 10 % | | Granulate: Montelukastum 4 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast-Mepha 4 | 28 piece(s) | 16.79 | 34.70 | 10 % | | Granulate: Montelukastum 4 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Sandoz 10 mg | 28 Tablet(s) | 16.79 | 34.70 | 10 % | | Coated tablets: Montelukastum 10 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Sandoz 10 mg | 98 Tablet(s) | 58.62 | 80.20 | 10 % | | Coated tablets: Montelukastum 10 mg | Sandoz Pharmaceuticals AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Spirig HC 10 | 30 | 18.00 | 35.95 | 10 % | | Coated tablets: Montelukastum 10 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Spirig HC 10 | 100 | 59.82 | 81.40 | 10 % | | Coated tablets: Montelukastum 10 mg | Spirig HealthCare AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Zentiva 10 mg | 28 | 16.70 | 34.60 | 10 % | | Coated tablets: Montelukastum 10 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast Zentiva 10 mg | 98 | 58.62 | 80.20 | 10 % | | Coated tablets: Montelukastum 10 mg | Helvepharm AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast-Mepha 10 mg | 28 Tablet(s) | 16.79 | 34.70 | 10 % | | Coated tablets: Montelukastum 10 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Montelukast-Mepha 10 mg | 98 Tablet(s) | 58.62 | 80.20 | 10 % | | Coated tablets: Montelukastum 10 mg | Mepha Pharma AG | B / SL / SG | FB | G |
| | | IP | CI | | Singulair 4 mg | 28 Sachet(s) | 19.96 | 37.95 | k.A. | | Granulate: Montelukastum 4 mg | Organon GmbH | B | FB | G |
|
| L | | IP | CI | | Nucala 100 mg/mL | | 976.63 | 1078.55 | 10 % | | Injektionslösung im Fertigpen: Mepolizumabum 100mg / 1ml | GlaxoSmithKline AG | B / SL | FB | G |
| L | | IP | CI | | Nucala 100 mg/mL | | 976.63 | 1078.55 | 10 % | | Injektionslösung in der Fertigspritze: Mepolizumabum 100mg / 1ml | GlaxoSmithKline AG | B / SL | FB | G |
|
| L | | IP | CI | | Fasenra 30 mg /1 ml | | 1929.05 | 2114.35 | 10 % | | Injection solution in prefilled syringe: Benralizumabum 30 mg/ml | AstraZeneca AG | B / SL | FB | G |
| L | | IP | CI | | Fasenra Pen 30 mg /1 ml | | 1929.05 | 2114.35 | 10 % | | lnjektionslösung: Benralizumabum 30 mg/ml | AstraZeneca AG | B / SL | FB | G |
|
| | | | CI | H | Regenaplex Nr. 24c | 15 ml | | | k.A. | | Tropfen zum Einnehmen: 10 Active Agents | Regena AG | D | FB | G |
| | | | CI | H | Regenaplex Nr. 24b | 15 ml | | | k.A. | | Tropfen zum Einnehmen: 10 Active Agents | Regena AG | D | FB | G |